SOURCES SOUGHT
99 -- Cryopreserved Platelets (CPP) for US FDA Licensure
- Notice Date
- 1/14/2025 9:35:27 AM
- Notice Type
- Sources Sought
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- ARMY MED RES ACQ ACTIVITY FORT DETRICK MD 21702 USA
- ZIP Code
- 21702
- Solicitation Number
- HT9425-25-RFI-PDM-01
- Response Due
- 1/20/2025 12:00:00 PM
- Archive Date
- 02/04/2025
- Point of Contact
- Peter Mitchell
- E-Mail Address
-
peter.d.mitchell8.civ@health.mil
(peter.d.mitchell8.civ@health.mil)
- Description
- United States Army Medical Materiel Development Activity seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. As part of the U.S. Combat Casualty Care Research Program, USAMMDA has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5 days at room temperature (20�C to 24�C) under gentle agitation.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/192b183028d34427a87e22a2da7c69e8/view)
- Place of Performance
- Address: Frederick, MD 21702, USA
- Zip Code: 21702
- Country: USA
- Zip Code: 21702
- Record
- SN07313015-F 20250116/250114230136 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |